UniProt | Protein Name |
---|---|
Q75T13 |
|
GO Term | Evidence Code | PMID |
---|---|---|
forebrain regionalization | ||
endoplasmic reticulum to Golgi vesicle-mediated transport | ||
protein transport | ||
attachment of GPI anchor to protein |
|
GO Term | Evidence Code | PMID |
---|---|---|
endoplasmic reticulum | ||
endoplasmic reticulum membrane |
|
GO Term | Evidence Code | PMID |
---|---|---|
phosphatidylinositol deacylase activity | ||
hydrolase activity, acting on ester bonds |
|
DO ID | Disease Name | Source |
---|---|---|
DOID:0060284 | paroxysmal nocturnal hemoglobinuria | |
DOID:0060308 | autosomal recessive intellectual developmental disorder | |
DOID:0060810 | syndromic X-linked intellectual disability type 10 | |
DOID:0060823 | syndromic X-linked intellectual disability 94 | |
DOID:0110881 | holoprosencephaly 1 | |
DOID:1059 | intellectual disability | |
DOID:10907 | microcephaly | |
DOID:11832 | visual epilepsy | |
DOID:12139 | dysthymic disorder | |
DOID:12859 | choreatic disease |
HPO ID | HPO Term |
---|---|
HP:0001257 | Spasticity |
HP:0001263 | Global developmental delay |
HP:0001270 | Motor delay |
HP:0001274 | Agenesis of corpus callosum |
HP:0001276 | Hypertonia |
HP:0001319 | Neonatal hypotonia |
HP:0001320 | Cerebellar vermis hypoplasia |
HP:0001344 | Absent speech |
HP:0001347 | Hyperreflexia |
HP:0001508 | Failure to thrive |
Disease ID | Disease Name |
---|---|
OMIM:615802 |
|
ORPHA:401820 |
|
Species | Gene ID | Alliance of Genome Resources | Orthologous MAtrix |
---|---|---|---|
101145385 | GORGO26440 | ||
100979650 | PANPA26324 | ||
745391 | PANTR29419 | ||
612828 | CANLF14080 | ||
112922906 | VULVU16194 | ||
123798162 | URSAM10829 | ||
100478076 | AILME11992 | ||
101681493 | MUSPF04934 | ||
101083194 | FELCA18362 | ||
122226431 | PANLE10861 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024